Supervisory Board

Chairman

Stefan von Holtzbrinck’s career in publishing began at Kirch Media Group, Bloomsbury and then in the New Media division of Holtzbrinck Publishing Group. He joined Macmillan Limited as a director in 1997 and then served as Managing Director at Nature Publishing Group. He joined Holtzbrinck Publishing Group as Chief Executive Officer in 2001. Dr von Holtzbrinck was born in 1963 in Ettlingen, Germany. He studied Law and Literature and earned his PhD in Media Law from the University of Munich.

Date appointed: 2018

Term expire: 2021

Partner or member of the administrative, management or supervisory bodies of:

• Verlagsgruppe Georg von Holtzbrinck GmbH (member of the executive board)
• Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (member of the board of directors (Verwaltungsrat))
• Business and Industry Advisory Board of the Goethe Institut (member of the board)

Deputy Chairman

Ewald Walgenbach was born in 1959 in Neustadt (Wied), Germany. After achieving a PhD and degree in biology from the Max Planck Institute for Plant Breeding Research in Cologne, Dr Walgenbach joined The Boston Consulting Group as a consultant. He went on to serve as the managing director of the chemicals division at Boehringer Ingelheim, and in strategic leadership roles in media companies including Bertelsmann, UFA Film + Fernseh GmbH, CLT-UFA and RTL Group. In 2002, he joined Bertelsmann as a member of the management board, where he also served as Chief Operating Officer and Chief Executive Officer of the DirectGroup division. Dr Walgenbach joined BC Partners in 2008 and currently serves as managing partner.

Date appointed: 2018

Term expires: 2021

Partner or member of the administrative, management or supervisory bodies of:

• Springer Science+Business Media GP Acquisition S.C.A. (member of the supervisory board)
• Aenova Holding GmbH (chairperson of the supervisory board)

Chair of Audit Committee

Simone Menne holds a degree in Business Administration from the University of Kiel, Germany and began her career as an auditor for ITT Corporation in the United States, later joining Deutsche Lufthansa. At Lufthansa Technik, she served as Vice President of Finance and Accounting, before joining British Midland as Chief Financial Officer in 2010. In 2012, Ms Menne joined Lufthansa as a member of the management board and was appointed Chief Financial Officer in 2016. She served as Chief Financial Officer at Boehringer Ingelheim from 2016 to 2017. Ms Menne is a member of the supervisory board of Deutsche Post and a member of the supervisory board of Bayerische Motoren Werke. She has served as chairperson of the supervisory board at various entities in the aviation industry.

Ms Menne was born in 1960 in Kiel, Germany.

Date appointed: 2018

Term expires: 2021

Partner or member of the administrative, management or supervisory bodies of:

• Bayerische Motoren Werke AG (member of the supervisory board)
• Deutsche Post AG (member of the supervisory board)
• Johnson Controls International plc (member of the supervisory board)

Obi Felten leads early stage projects at X, Alphabet’s moonshot factory, responsible for getting early stage projects from the lab into the real world, or ensuring they fail fast. Previously she was Director of Consumer Marketing for Google in Europe, Middle East and Africa. Before Google, Ms Felten launched the ecommerce business of a major UK retailer, worked as a strategy consultant, and led eToys.com's (unsuccessful) expansion to Germany during the first dotcom era. She is a startup mentor and angel investor, with a focus on women entrepreneurs.

Born in Saarbrücken, Germany in 1973, Ms Felten grew up in Berlin and has a BA in Philosophy and Psychology from Oxford University and today lives in San Franscisco.

Date appointed: 2018

Term expires: 2021

Partner or member of the administrative, management or supervisory bodies of:

• X, Alphabet (product management director)
• Shift (trustee)
• Picasso Labs (board member)

Stefan Oschmann joined Merck in 2011 as a member of the Executive Board and was responsible for the Healthcare business sector until the end of 2014. In 2016, he was appointed Chairman of the Executive Board and CEO of Merck and prior to that served as Vice Chairman and Deputy CEO, with responsibility for Group Strategy. Before joining Merck, Dr Oschmann worked for the US pharma company MSD, where he served in a range of senior executive positions. He started his career at an agency of the United Nations, and worked for the German Chemical Industry Association (VCI).

Dr Oschmann was born in Würzburg, Germany in 1957. He holds a doctorate in Veterinary Medicine from Ludwig-Maximilians-Universität in Munich.

Date appointed: 2018

Term expires: 2021

Partner or member of the administrative, management or supervisory bodies of:

• Merck KGaA (chairman of the executive board and chief executive officer)
• European Federation of Pharmaceutical Industries and Associations (president)
• Deutsche Welle (member of the business advisory board)
• Verband der Chemischen Industrie e.V. (VCI) (member of the executive committee)
• Allianz SE (member of the joint advisory board of the Allianz companies)

Bernd Scheifele was born in 1958 in Freiburg, Germany. Dr Scheifele studied law at the University of Freiburg, Germany, and at the University of Burgundy, Dijon, France. He holds a Master of Laws degree from the University of Illinois, United States and a PhD in law from the University of Freiburg, Germany. Dr Scheifele started his career as an attorney at the law firm Gleiss Lutz Hootz Hirsch in 1988. In 1994, he became the chairman of PHOENIX Pharmahandel. In 2005, Dr Scheifele joined HeidelbergCement as Chief Executive Officer. In 2005, Dr Scheifele was appointed as chairman of the advisory board of PHOENIX Pharmahandel. In 2006, he was appointed as a member of the supervisory board of Verlagsgruppe Georg von Holtzbrinck GmbH.

Date appointed: 2018

Term expires: 2021

Partner or member of the administrative, management or supervisory bodies of:

• HeidelbergCement AG (chief executive officer)
• PHOENIX Pharma SE (chairman of the supervisory board)
• PHOENIX Pharmahandel GmbH & Co. KG (chairman of the advisory board)
• Verlagsgruppe Georg von Holtzbrinck GmbH (member of the supervisory board)